Samil Pharm (000520) - Total Liabilities

Latest as of June 2025: ₩226.31 Billion KRW ≈ $153.37 Million USD

Based on the latest financial reports, Samil Pharm (000520) has total liabilities worth ₩226.31 Billion KRW (≈ $153.37 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Samil Pharm (000520) cash flow conversion to assess how effectively this company generates cash.

Samil Pharm - Total Liabilities Trend (2011–2024)

This chart illustrates how Samil Pharm's total liabilities have evolved over time, based on quarterly financial data. Check financial resilience of Samil Pharm to evaluate the company's liquid asset resilience ratio.

Samil Pharm Competitors by Total Liabilities

The table below lists competitors of Samil Pharm ranked by their total liabilities.

Company	Country	Total Liabilities
Diginex Limited Ordinary Shares NASDAQ:DGNX	USA	$4.20 Million
Reliance Industrial Infrastructure Limited NSE:RIIL	India	Rs662.20 Million
Shaver Shop Group Ltd AU:SSG	Australia	AU$71.65 Million
Sungdo Engineering & Construction Co. Ltd KQ:037350	Korea	₩301.05 Billion
NET Power Inc. NYSE:NPWR	USA	$64.50 Million
Super Energy Corporation Public Company Limited BK:SUPER-R	Thailand	฿50.49 Billion
Haivision Systems Inc TO:HAI	Canada	CA$47.46 Million
King Core Electronics Inc TW:6155	Taiwan	NT$649.91 Million

Liability Composition Analysis (2011–2024)

This chart breaks down Samil Pharm's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market cap of Samil Pharm.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	0.63	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	1.52	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.60	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Samil Pharm's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Samil Pharm (2011–2024)

The table below shows the annual total liabilities of Samil Pharm from 2011 to 2024.

Year	Total Liabilities	Change
2024-12-31	₩218.95 Billion ≈ $148.38 Million	-9.84%
2023-12-31	₩242.85 Billion ≈ $164.58 Million	+5.19%
2022-12-31	₩230.88 Billion ≈ $156.46 Million	+43.71%
2021-12-31	₩160.66 Billion ≈ $108.88 Million	+25.41%
2020-12-31	₩128.11 Billion ≈ $86.82 Million	+5.35%
2019-12-31	₩121.60 Billion ≈ $82.41 Million	+32.37%
2018-12-31	₩91.87 Billion ≈ $62.26 Million	+8.96%
2017-12-31	₩84.31 Billion ≈ $57.14 Million	+75.19%
2016-12-31	₩48.12 Billion ≈ $32.61 Million	+7.18%
2015-12-31	₩44.90 Billion ≈ $30.43 Million	-15.08%
2014-12-31	₩52.88 Billion ≈ $35.83 Million	+15.75%
2013-12-31	₩45.68 Billion ≈ $30.96 Million	-5.07%
2012-12-31	₩48.12 Billion ≈ $32.61 Million	-11.86%
2011-12-31	₩54.60 Billion ≈ $37.00 Million	--

About Samil Pharm

KO:000520 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$127.90 Million

₩188.73 Billion KRW

Market Cap Rank

#18246 Global

#908 in Korea

Share Price

₩8890.00

Change (1 day)

-2.31%

52-Week Range

₩8670.00 - ₩12810.00

All Time High

₩23603.13